| Basics |
ProPhase Labs, Inc.
ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is also engaged in the research and development of potential over-the-counter drug, natural health products, supplements, personal care & cosmeceutical products.
|
| IPO Date: |
May 1, 1994 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$6M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 3.65%
|
| Avg Daily Range (30 D): |
$0.02 | 6.94%
|
| Avg Daily Range (90 D): |
$0.02 | 5.97%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.29M |
| Avg Daily Volume (30 D): |
2.2M |
| Avg Daily Volume (90 D): |
4.17M |
| Trade Size |
| Avg Trade Size (Sh.): |
446 |
| Avg Trade Size (Sh.) (30 D): |
696 |
| Avg Trade Size (Sh.) (90 D): |
713 |
| Institutional Trades |
| Total Inst.Trades: |
10 |
| Avg Inst. Trade: |
$1.27M |
| Avg Inst. Trade (30 D): |
$4.5M |
| Avg Inst. Trade (90 D): |
$4.5M |
| Avg Inst. Trade Volume: |
.33M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.36M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
127.12K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.78
|
$-.16
|
|
|
Diluted EPS
|
$-1.78
|
$-.16
|
|
|
Revenue
|
$ 5.06M
|
$ .88M
|
$
|
|
Gross Profit
|
$ 2.06M
|
$ -.12M
|
$
|
|
Net Income / Loss
|
$ -41.7M
|
$ -6.84M
|
$
|
|
Operating Income / Loss
|
$ -29.61M
|
$ -4.76M
|
$
|
|
Cost of Revenue
|
$ 4.07M
|
$ 1.01M
|
$
|
|
Net Cash Flow
|
$ -.1M
|
$
|
$
|
|
PE Ratio
|
|
|
|
|
|
|
